“…In some studies, no difference with M-protein-producing cases could be recognized [10], whereas other studies found a less advanced disease and/or less impaired immunoglob ulin values in nonsecretory patients [6,8,12,14,16]. Similarly, controversies also exist as to whether the clinical course and prognosis of this disease variant are different from those of typical myelomatosis [2,3,6,12], In order to investigate whether nonsecretory mye loma is a distinct clinical entity we analyzed a series 1 of 7 consecutive patients. We found that all but 1 of them had high tumor cell mass stage, and that the le vels of normal immunoglobulins in this group were more markedly depressed than in the secretory group.…”